Christine Conroy
Nessuna posizione attualmente
Profilo
Christine Conroy worked as a Senior Director of Regulatory Affairs at Genitope Corp.
from 2002 to 2004.
Prior to that, she was a Regulatory Program Director at Roche Global Development from 1995 to 2001.
From 2009 to 2013, she served as the VP of Regulatory Affairs & Good Clinical Practice at Affymax, Inc. In addition, she was the Manager of the Medical Services Department at Syntex Laboratories, Inc. from 1989 to 1994.
Most recently, she worked as the Senior Vice President of Regulatory Affairs at Dermira, Inc. from 2014 to 2018.
Conroy holds a doctorate degree from KU School of Pharmacy and an undergraduate degree from the University of Colorado School of Pharmacy.
Precedenti posizioni note di Christine Conroy
| Società | Posizione | Fine |
|---|---|---|
| DERMIRA, INC. | Consigliere Generale | 01/09/2018 |
| GENITOPE CORPORATION | Consigliere Generale | 01/01/2004 |
| Roche Global Development | Corporate Officer/Principal | 01/01/2001 |
| Syntex Laboratories, Inc. | Corporate Officer/Principal | 01/01/1994 |
| AFFYMAX, INC. | Consigliere Generale | - |
Formazione di Christine Conroy
| KU School of Pharmacy | Doctorate Degree |
| University of Colorado School of Pharmacy | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AFFYMAX, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Genitope Corp.
 Genitope Corp. BiotechnologyHealth Technology Genitope Corp. operates as a biotechnology company, which focuses on the research and development of novel immunotherapies for the treatment of cancer. The company was founded on August 15, 1996 and is headquartered in Redwood, CA. | Health Technology |
| Syntex Laboratories, Inc. | |
| Roche Global Development | |
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Dermira, Inc. is a biopharmaceutical company. It engages in the provision of therapies for chronic skin conditions. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Indianapolis, IN. | Health Technology |
- Borsa valori
- Insiders
- Christine Conroy